| 2932.99.61 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 52% |
| 2933 | | Heterocyclic compounds with nitrogen hetero-atom(s) only: | | | | |
| 2933.11.00 | 00 | Compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.19.04 | 00 | Aromatic or modified aromatic: | | | | |
| 2933.19.08 | 00 | 3-(5-Amino-3-methyl-1H-pyrazol-1-yl)- benzenesulfonic acid; Amino-J-pyrazolone; 3-Amino-1-(2,4,6-trichlorophenyl)-5- pyrazolone; 3-Carboxy-1,4-sulfophenylpyrazol-5-one; 4-Chloro-3-(3-methyl-5-oxo-2-pyrazolin-1- yl)benzenesulfonic acid; 1-(m-Chlorophenyl)-3-methyl-2-pyrazolin- 5-one; p-Chloropyrazolone; 1-(2',5'-Dichlorophenyl)-3-methyl-2- pyrazolin-5-one; 1-(o-Ethylphenyl)-3-methyl-2-pyrazolin- 5-one; 5-Imino-3-methyl-1-phenylpyrazole; 5-Imino-3-methyl-1-(m-sulfophenyl)- pyrazole; 2,4-Methylcarboxypyrazolic acid; Methylphenylpyrazolone; and Sulfinpyrazone | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P,SG) | 15.4¢/kg + 39.5% |
| 2933.19.18 | 00 | 2-Chloro-5-sulfophenylmethylpyrazolone; 2,5-Dichloro-4-(3-methyl-5-oxo-2- pyrazolin-1-yl) benzenesulfonic acid; Phenylcarbethoxypyrazolone; m-Sulfaminopyrazolone (m-Sulfamido- phenylmethylpyrazolone); and 1-(p-Sulfophenyl)-3-methylpyrazolone | kg | Free | | 15.4¢/kg + 52% |
| 2933.19.37 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 52% |
| 2933.21.00 | 00 | Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.29.05 | 00 | Aromatic or modified aromatic: | | | | |
| 2933.29.05 | 00 | 1-[1-((4-Chloro-2-(trifluoromethyl)phenyl)- imino)-2-propoxyethyl]-1H-imidazole (Triflumizole); and Ethylene thiourea | kg | Free | | 15.4¢/kg + 52% |
| 2933.29.35 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4¢/kg + 52% |
| 2933.31.00 | 00 | Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.33.00 | 00 | Alfentanil (INN), anileridine (INN), bezitramide (INN), bromazepam (INN), difenoxin (INN), diphenoxylate (INN), dipipanone (INN), fentanyl (INN), ketobemidone (INN), methylphenidate (INN), pentazocine (INN), pethidine (INN), pethidine (INN) intermediate A, phencyclidine (INN) (PCP), phenoperidine (INN), pipradrol (INN), piritramide (INN), propiram (INN) and trimeperidine (INN); salts thereof | kg | Free | | 15.4¢/kg + 149.5% |
| 2933.39.08 | 00 | 1-(3-Sulfopropyl)pyridinium hydroxide; N,N'-Bis(2,2,6,6-tetramethyl-4-piperidinyl)-1,6- hexanediamine; 3,5-Dimethyl-2-hydroxymethyl-4-methoxy- pyridine (pyrmethyl alcohol); Dipentamethylenethiuram tetrasulfide; 2H-Indol-2-one,1,3-dihydro-1-phenyl-3-(4- pyridinylmethylene); 4-Picolyl chloride hydrochloride; and Piperidinoethyl chloride hydrochloride | kg | Free | | 15.4¢/kg + 52% |
| 2933.39.20 | 00 | p-Chloro-2-benzylpyridine; 4-Chloro-1-methylpiperidine hydrochloride; 1,4-Dimethyl-6-hydroxy-3-cyanopyrid-2-one; Di-(2,2,6,6-tetramethyl-4-hydroxy- piperidine)sebacate; 2-Methyl-5-ethylpyridine; 4-Phenylpropylpyridine; α-Phenylpyridylacetic acid, methyl ester; Picolinic acid; 2-Pyridinecarboxaldehyde; and 2,5-Pyridinedicarboxylic acid | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4¢/kg + 39.5% |
| 2933.39.61 | | Products described in additional U.S. note 3 to section VI | | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 52% |
| 2933.41.00 | 00 | Compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused: | | | | |
| 2933.49.08 | 00 | 4,7-Dichloroquinoline | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 0.2¢/kg + 3.1% (SG) | 15.4¢/kg + 52% |
| 2933.49.10 | 00 | Ethoxyquin (1,2-Dihydro-6-ethoxy-2,2,4- trimethylquinoline) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4¢/kg + 55% |
| 2933.49.17 | 00 | Ethyl ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylate | kg | Free | | 15.4¢/kg + 52% |
| 2933.49.20 | 00 | 5-Chloro-7-iodo-8-quinolinol (Iodochlorhydroxyquin); Decoquinate; Diiodohydroxyquin; and Oxyquinoline sulfate | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4¢/kg + 46% |
| 2933.49.60 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 52% |
| 2933.52 | | Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure: | | | | |
| 2933.55.00 | 00 | Loprazolam (INN), mecloqualone (INN), methaqualone (INN) and zipeprol (INN); salts thereof | kg | Free | | 15.4¢/kg + 149.5% |
| 2933.59.10 | 00 | Aromatic or modified aromatic: | | | | |
Harmonized Tariff Schedule of the United States inquiry: gaming
